| Literature DB >> 29385762 |
Mamta Dhaneria1, Sachin Jain2, Poonam Singh3, Aditya Mathur4, Cecilia Stålsby Lundborg5, Ashish Pathak6,7,8.
Abstract
Very little is known about laboratory-confirmed blood stream infections (LCBIs) in neonatal intensive care units (NICUs) in resource-limited settings. The aim of this cohort study was to determine the incidence, risk factors, and causative agents of LCBIs in a level-2 NICU in India. The diagnosis of LCBIs was established using the Centre for Disease Control, USA criteria. A predesigned questionnaire containing risk factors associated with LCBIs was filled-in. A total of 150 neonates (43% preterm) were included in the study. The overall incidence of LCBIs was 31%. The independent risk factors for LCBIs were: preterm neonates (relative risk (RR) 2.23), duration of NICU stay more than 14 days (RR 1.75), chorioamnionitis in the mother (RR 3.18), premature rupture of membrane in mothers (RR 2.32), neonate born through meconium-stained amniotic fluid (RR 2.32), malpresentation (RR 3.05), endotracheal intubation (RR 3.41), umbilical catheterization (RR 4.18), and ventilator-associated pneumonia (RR 3.17). The initiation of minimal enteral nutrition was protective from LCBIs (RR 0.22). The predominant causative organisms were gram-negative pathogens (58%). The results of the present study can be used to design and implement antibiotic stewardship policy and introduce interventions to reduce LCBIs in resource-limited settings.Entities:
Keywords: India; antibiotic resistance; antibiotic use; blood stream health care associated infections; neonatal intensive care unit; neonates; risk factors
Year: 2018 PMID: 29385762 PMCID: PMC5871960 DOI: 10.3390/diseases6010014
Source DB: PubMed Journal: Diseases ISSN: 2079-9721
Multivariate analysis of neonatal and maternal characteristics associated with laboratory-confirmed blood stream infections in a cohort of 150 neonates.
| Risk Factors | Total (%) * | HAI | RR | 95% CI | ||
|---|---|---|---|---|---|---|
| 150 | No (%) # | Yes (%) # | ||||
| Sex | ||||||
| Female | 55 (37) | 40 (73) | 15 (27) | Reference | Reference | |
| Male | 95 (63) | 64 (67) | 31 (33) | 1.91 | 0.71–2.01 | 0.498 |
| Gestational age | ||||||
| Term | 85 (57) | 68 (80) | 17 (20) | Reference | Reference | |
| Preterm | 65 (43) | 36 (55) | 29 (45) | 2.23 | 1.34–3.69 | 0.002 |
| Duration of NICU stay | ||||||
| Up to 14 days | 115 (77) | 85 (74) | 30 (26) | Reference | Reference | |
| >14 days | 35 (23) | 19 (54) | 16 (46) | 1.75 | 1.09–2.81 | 0.020 |
| Choroamnionitis in mother | ||||||
| No | 142 (95) | 103 (73) | 39 (27) | Reference | Reference | |
| Yes | 8 (5) | 01 (12) | 7 (88) | 3.18 | 2.19–4.63 | <0.001 |
| PROM in mother | ||||||
| No | 129 (86) | 97 (75) | 32 (25) | Reference | Reference | |
| Yes | 21 (14) | 7 (33) | 14 (67) | 2.68 | 1.75–4.11 | <0.001 |
| Meconium stained amniotic fluid | ||||||
| No | 134 (89) | 98 (73) | 36 (27) | Reference | Reference | |
| Yes | 16 (11) | 6 (37) | 10 (13) | 2.32 | 1.45–3.72 | <0.001 |
| Malpresentation | ||||||
| No | 136 (91) | 101 (74) | 35 (26) | Reference | Reference | |
| Yes | 14 (9) | 3 (21) | 11 (79) | 3.05 | 2.05–4.53 | <0.001 |
| Birth asphyxia | ||||||
| No | 122 (81) | 86 (70) | 36 (30) | Reference | Reference | |
| Yes | 28 (19) | 18 (64) | 10 (36) | 1.21 | 0.68–2.13 | 0.510 |
| ET intubation | ||||||
| No | 128 (85) | 99 (77) | 29 (23) | Reference | Reference | |
| Yes | 22 (15) | 5 (23) | 17 (77) | 3.41 | 2.30–5.04 | <0.001 |
| Umbilical catheterization | ||||||
| No | 119 (79) | 97 (82) | 22 (18) | Reference | Reference | |
| Yes | 31 (31) | 7 (23) | 24 (77) | 4.18 | 2.74–6.38 | <0.001 |
| VAP | ||||||
| No | 135 (90) | 101 (75) | 34 (25) | Reference | Reference | |
| Yes | 15 (10) | 3 (20) | 12 (80) | 3.17 | 2.16–4.67 | <0.001 |
| Minimal enteral nutrition | ||||||
| No | 114 (76) | 71 (62) | 43 (38) | |||
| Yes | 36 (24) | 33 (92) | 3 (8) | 0.22 | 0.07–0.66 | 0.008 |
# Row percentage, * Column percentage PROM-premature rupture of membrane, ET-endotracheal tube, VAP-ventilator associated pneumonia.
The antibiotic-resistance-pattern of the most prevalent causes of laboratory-confirmed blood stream infections in a cohort of 150 neonates.
| Antimicrobial Class/Agent Tested | Activity by Organism (Number Tested) | |||||
|---|---|---|---|---|---|---|
| R (%) | R (%) | R (%) | R (%) | R (%) | R (%) | |
| Ampicillin | 10 (91) | - | 4 (80) | 3 (75) | 8 (80) | 7 (88) |
| Amoxicillin/clavulanate | 9 (82) | - | 4 (80) | 3 (75) | 7 (70) | 7 (88) |
| Piperacillin/tazobactam | 4 (36) | 4 (67) | 2 (40) | 1 (25) | - | - |
| Cefuroxime | 9 (82) | - | 4 (80) | 3 (75) | - | - |
| Ceftriaxone | 8 (73) | - | 3 (60) | 1 (25) | - | - |
| Cefixime | 9 (82) | - | 4 (80) | 1 (25) | - | - |
| Ceftazidime | 7 (64) | 5 (83) | 4 (80) | 1 (25) | - | - |
| Ciprofloxacin | 9 (82) | 5 (83) | 3 (60) | 3 (75) | - | - |
| Norfloxacin | 9 (82) | - | 3 (60) | - | - | - |
| Ofloxacin | 9 (82) | - | 3 (60) | 2 (50) | - | - |
| Levofloxacin | - | - | - | - | 3 (30) | 1 (13) |
| Gentamicin | 7 (64) | 4 (67) | 3 (60) | 1 (25) | - | - |
| Amikacin | 4 (36) | 2 (33) | 1 (20) | 1 (25) | 2 (20) | 1 (13) |
| Chloramphenicol | 6 (55) | 4 (67) | 3 (60) | 1 (25) | - | - |
| Tetracycline | 10 (91) | 5 (83) | 4 (80) | 2 (50) | - | - |
| Co-trimoxazole | 9 (82) | 5 (83) | 4 (80) | 3 (75) | - | - |
| Cefoxitin | - | - | - | - | 3 (30) | - |
| Vancomycin | - | - | - | - | 0 (0) | 0 (0) |
| Imipenem | - | - | - | - | 1 (10) | 1 (13) |